S. A. Hamza, N. I. A. Haddad, and G. A. Gawwam, “The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study”, IJASIS, pp. 335–345, Feb. 2026, doi: 10.29284/x4mwhb26.